Company
Cajal Therapeutics
Cajal Therapeutics is developing novel medicines for serious diseases, including anemias of inflammation, neurodegenerative diseases, and other iron-related disorders.
Also known as Cajal Neuroscience, Inc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Cajal Neuroscience, Inc
- cajal-tx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are developing small molecule and RNA medicines that restore iron homeostasis across systemic and neurologic diseases. Our lead program, CTX001, is a first-in-class iron mobilizer designed to restore iron transport and make iron available again to key metabolic and cellular processes.
Products
- Other
- CTX001
Loading relationship preview